A team of experimental oncology researchers at the University of Alberta is shedding light on how the deadly brain cancer ...

A nationwide effort that includes many California researchers seeks to find out why some Asian American communities have high ...

There is mounting evidence to suggest GLP-1 drugs designed as diabetes and obesity treatments also help reduce cancer risk.

Creatine, the organic acid that is popularly taken as a supplement by athletes and bodybuilders, supercharges a critical ...

Dysregulated immunity and chronic inflammation are key contributors to cancer development, progression, and therapy response. Persistent inflammatory ...

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the ...

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

A new University of California study says that a toxic carcinogen with "potentially serious impacts on human health" may have ...

A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, ...

A newly published review article brings attention to the expanding role of RBM15, a critical regulator of RNA m6A methylation, in the development and progression of a wide range of diseases, including ...

Cancer cells survive by repairing damage to their DNA—even damage that would normally be fatal. One of their most important defense systems is homologous recombination, a high-precision repair pathway ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...